The third international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation
Despite recent advances, cytomegalovirus (CMV) infections remain one of the most common
complications affecting solid organ transplant recipients, conveying higher risks of …
complications affecting solid organ transplant recipients, conveying higher risks of …
Progress and challenges in the prevention, diagnosis, and management of cytomegalovirus infection in transplantation
Hosts with compromised or naive immune systems, such as individuals living with HIV/AIDS,
transplant recipients, and fetuses, are at the highest risk for complications from …
transplant recipients, and fetuses, are at the highest risk for complications from …
Cytomegalovirus in solid organ transplant recipients—Guidelines of the American Society of Transplantation Infectious Diseases Community of Practice
RR Razonable, A Humar - Clinical transplantation, 2019 - Wiley Online Library
Cytomegalovirus (CMV) is one of the most common opportunistic infections that affect the
outcome of solid organ transplantation. This updated guideline from the American Society of …
outcome of solid organ transplantation. This updated guideline from the American Society of …
New insights on CMV management in solid organ transplant patients: prevention, treatment, and management of resistant/refractory disease
CN Kotton, N Kamar - Infectious Diseases and Therapy, 2023 - Springer
Cytomegalovirus (CMV) infection can have both direct and indirect effects after solid-organ
transplantation, with a significant impact on transplant outcomes. Prevention strategies …
transplantation, with a significant impact on transplant outcomes. Prevention strategies …
[HTML][HTML] Cytomegalovirus infection after liver transplantation
BC Lizaola-Mayo, EA Rodriguez - World Journal of Transplantation, 2020 - ncbi.nlm.nih.gov
Human cytomegalovirus (CMV) represents the most common opportunistic infection in liver
transplant recipients. CMV infections in post liver transplant patients cause significant …
transplant recipients. CMV infections in post liver transplant patients cause significant …
Utility of CMV-specific immune monitoring for the management of CMV in solid organ transplant recipients: a clinical update
K Prakash, A Chandorkar, KK Saharia - Diagnostics, 2021 - mdpi.com
Cytomegalovirus (CMV) is one of the most important opportunistic infections in solid organ
transplant (SOT) recipients. However, current techniques used to predict risk for CMV …
transplant (SOT) recipients. However, current techniques used to predict risk for CMV …
Cytomegalovirus and other herpesviruses after hematopoietic cell and solid organ transplantation: From antiviral drugs to virus-specific T cells
T Ivana, P Robert, S Pavel, T Lenka, K Irena - Transplant Immunology, 2022 - Elsevier
Herpesviruses can either cause primary infection or may get reactivated after both
hematopoietic cell and solid organ transplantations. In general, viral infections increase post …
hematopoietic cell and solid organ transplantations. In general, viral infections increase post …
Screening of novel drugs for inhibiting hepatitis E virus replication
T Nishiyama, T Kobayashi, S Jirintai, I Kii… - Journal of virological …, 2019 - Elsevier
Hepatitis E, which is caused by hepatitis E virus (HEV), is generally a self-limiting, acute, and
rarely fatal disease. It is sometimes fulminant and lethal, especially during pregnancy …
rarely fatal disease. It is sometimes fulminant and lethal, especially during pregnancy …
Intestinal transplantation: a review
L Loo, G Vrakas, S Reddy, P Allan - Current opinion in …, 2017 - journals.lww.com
With advancements in immunosuppressive drugs, induction regimens, standardization of
surgical techniques and improved postoperative care, survival is increasing. In due course, it …
surgical techniques and improved postoperative care, survival is increasing. In due course, it …
Management of Cytomegalovirus Infections in the Era of the Novel Antiviral Players, Letermovir and Maribavir
Cytomegalovirus (CMV) infections may increase morbidity and mortality in
immunocompromised patients. Until recently, standard antiviral drugs against CMV were …
immunocompromised patients. Until recently, standard antiviral drugs against CMV were …